- Home
- ARTW vs LGVN Comparison
ARTW vs LGVN Comparison
Compare ARTW & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | LGVN |
|---|---|---|
| Founded | 1956 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 11.9M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARTW | LGVN |
|---|---|---|
| Price | $2.21 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 47.9K | ★ 8.8M |
| Earning Date | 02-19-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | 50.76 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $22,975,408.00 | $709,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,183.95 |
| P/E Ratio | $11.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.43 | $0.48 |
| 52 Week High | $4.69 | $1.83 |
Technical Indicators
Market Signals| Indicator | ARTW | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 59.73 |
| Support Level | $2.11 | $0.60 |
| Resistance Level | $2.49 | $0.99 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 18.29 | 63.57 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.